clopidogrel and abt-333

clopidogrel has been researched along with abt-333 in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	6 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Stark, JE	1
Badri, P; Bow, D; Fischer, V; Fu, W; Shebley, M	1
Arya, V; Mishra, P; Reynolds, KS; Younis, IR; Zhao, P	1
Backman, JT; Itkonen, MK; Lapatto-Reiniluoto, O; Neuvonen, M; Neuvonen, PJ; Niemi, M; Tornio, A	2
Shebley, M	1

Trials

1 trial(s) available for clopidogrel and abt-333

Article	Year
Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. Clinical pharmacology and therapeutics, 2019, Volume: 105, Issue:1 Topics: 2-Naphthylamine; Adult; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Platelet Aggregation Inhibitors; Ritonavir; Sulfonamides; Uracil; Young Adult	2019

Article

Year

Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel.

Clinical pharmacology and therapeutics, 2019, Volume: 105, Issue:1

Topics: 2-Naphthylamine; Adult; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Platelet Aggregation Inhibitors; Ritonavir; Sulfonamides; Uracil; Young Adult

2019

Other Studies

5 other study(ies) available for clopidogrel and abt-333

Article	Year
Potential for a Significant Interaction Between Clopidogrel and Dasabuvir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jul-01, Volume: 61, Issue:1 Topics: 2-Naphthylamine; Antiviral Agents; Clopidogrel; Drug Interactions; Enzyme Inhibitors; Hepatitis C, Chronic; Humans; Sulfonamides; Ticlopidine; Torsades de Pointes; Uracil	2015
Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction Between Clopidogrel and Dasabuvir. Clinical pharmacology and therapeutics, 2017, Volume: 102, Issue:4 Topics: 2-Naphthylamine; Antiviral Agents; Area Under Curve; Clopidogrel; Cytochrome P-450 CYP2C8; Drug Interactions; Glucuronides; Humans; In Vitro Techniques; Models, Biological; Sulfonamides; Ticlopidine; Uracil	2017
Utilizing PBPK Modeling to Evaluate the Potential of a Significant Drug-Drug Interaction Between Clopidogrel and Dasabuvir: A Scientific Perspective. Clinical pharmacology and therapeutics, 2017, Volume: 102, Issue:4 Topics: 2-Naphthylamine; Antiviral Agents; Clopidogrel; Cytochrome P-450 CYP2C8; Drug Combinations; Drug Interactions; Glucuronides; Humans; Macrocyclic Compounds; Models, Biological; Ritonavir; Sulfonamides; Ticlopidine; Uracil	2017
Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test? Clinical pharmacology and therapeutics, 2019, Volume: 105, Issue:2 Topics: 2-Naphthylamine; Clopidogrel; Ritonavir; Sulfonamides; Uracil	2019
Response to "Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?" Clinical pharmacology and therapeutics, 2019, Volume: 105, Issue:2 Topics: 2-Naphthylamine; Clopidogrel; Ritonavir; Sulfonamides; Uracil	2019